BUSINESS NEWS
Avigen Drops ‘Gene Therapy’ Research
After twelve unprofitable years, Avigen Inc. has decided to stop funding its experimental gene therapy platform and instead focus its limited capital on developing traditional pharmaceuticals.
Article
Genetic Engineering News Publishes Annual Listing of Molecular Millionaires
Article
Anormed Files IND To Evaluate Potential Of AMD3100 To Repair Damaged Heart Tissue In Cardiac Patients
AnorMED Inc. announced today that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration for approval to begin its clinical program for AMD3100 in cardiac patients. The filing is the first step in evaluating the potential of AMD3100, a stem cell mobilizer, to help repair damaged heart tissue in patients who have suffered heart attacks.
Article
Invitrogen Completes Acquisition of Dynal
Article
Chemicon International, Inc. Expands its Exclusive Agreement for Patented Compounds and Methods for Embryonic Stem – ES – Cell Research
Article
Bio-Matrix Scientific Group Announced Today That Collective Technologies Will Manufacture Stem Cell Instrument Molds
Article
Human BioSystems Advances Donor Organ Preservation Results to a New Level
Article
Geron And Exeter Life Sciences Form Joint Venture For Licensing Animal Cloning Technologies
Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. announced today the formation of stART Licensing, Inc., a new company that will manage and license a broad portfolio of intellectual property rights related to animal reproductive technologies.
Article
ICOS, Caprion Pharmaceuticals Enter Into Joint Development Collaboration
ICOS and Caprion Pharmaceuticals have entered into an agreement for the joint development of therapeutic antibodies for the treatment of cancer.
Article
Australia’s Mesoblast Makes Rapid Progress Towards Adult Stem Cell Clinical Trials
Article
Mesoblast Receives $1.5 million Adult Stem Cell Grant
Article
Takara Bio, MolMed Conclude R&D Agreement for HIV Gene Therapy Treatment
Article
MARKET REPORTS
Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer.
“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:
Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form
“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.
A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents
Immunotherapy Reports Order Form